1649 / 1840
HDR PROSTATE BRACHYTHERAPY
INDICATIONS
•
Boost with external beam therapy
– Intermediate/high risk disease
•
PSA10-20
•
Gleason 7+
•
T2c T3
•
Monotherapy
– Intermediate risk disease
– ? Good risk disease vs seeds
|
|
1649 / 1840
HDR PROSTATE BRACHYTHERAPY
INDICATIONS
•
Boost with external beam therapy
– Intermediate/high risk disease
•
PSA10-20
•
Gleason 7+
•
T2c T3
•
Monotherapy
– Intermediate risk disease
– ? Good risk disease vs seeds